Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
EZZ Life Science Holdings Ltd. (AU:EZZ)
ASX:EZZ
Holding AU:EZZ?
Track your performance easily
EZZ Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.45 - AU$4.97
Previous CloseAU$2.87
Volume5.55K
Average Volume (3M)170.79K
Market Cap
AU$132.70M
Enterprise ValueAU$122.34M
Total Cash (Recent Filing)AU$10.46M
Total Debt (Recent Filing)AU$104.57K
Price to Earnings (P/E)17.8
Beta-0.46
Next Earnings
Mar 03, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 05, 2024Dividend Yield0.87%
Share Statistics
EPS (TTM)0.16
Shares OutstandingN/A
10 Day Avg. Volume115,978
30 Day Avg. Volume170,789
Standard Deviation0.22
R-Squared0.01
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.73
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EZZ Life Science Holdings Ltd. News
PremiumCompany Announcements
EZZ Life Science Joins MSCI World Micro Cap Index
PremiumCompany Announcements
EZZ Life Science Expands Trading with New Securities
PremiumCompany Announcements
EZZ Life Science Announces Upcoming Dividend Payment
PremiumCompany Announcements
EZZ Life Science Outlines Key AGM Resolutions
PremiumCompany Announcements
EZZ Life Science Holdings Reports Robust Growth and Strategic Expansion
PremiumCompany Announcements
EZZ Life Science Upholds Strong Corporate Governance
PremiumCompany Announcements
EZZ Life Science Unveils 2024 Financial Report
PremiumCompany Announcements
EZZ Life Science Applies for New ASX QuotationEZZ FAQ
What was EZZ Life Science Holdings Ltd.’s price range in the past 12 months?
EZZ Life Science Holdings Ltd. lowest share price was AU$0.45 and its highest was AU$4.97 in the past 12 months.
What is EZZ Life Science Holdings Ltd.’s market cap?
Currently, no data Available
When is EZZ Life Science Holdings Ltd.’s upcoming earnings report date?
EZZ Life Science Holdings Ltd.’s upcoming earnings report date is Mar 03, 2025 which is in 101 days.
How were EZZ Life Science Holdings Ltd.’s earnings last quarter?
EZZ Life Science Holdings Ltd. released its earnings results on Aug 27, 2024. The company reported AU$0.135 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.135.
Is EZZ Life Science Holdings Ltd. overvalued?
According to Wall Street analysts EZZ Life Science Holdings Ltd.’s price is currently Overvalued.
Does EZZ Life Science Holdings Ltd. pay dividends?
EZZ Life Science Holdings Ltd. pays a Annually dividend of AU$0.02 which represents an annual dividend yield of 0.87%. See more information on EZZ Life Science Holdings Ltd. dividends here
What is EZZ Life Science Holdings Ltd.’s EPS estimate?
EZZ Life Science Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EZZ Life Science Holdings Ltd. have?
EZZ Life Science Holdings Ltd. has 46,158,200 shares outstanding.
What happened to EZZ Life Science Holdings Ltd.’s price movement after its last earnings report?
EZZ Life Science Holdings Ltd. reported an EPS of AU$0.135 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 22.165%.
Which hedge fund is a major shareholder of EZZ Life Science Holdings Ltd.?
Currently, no hedge funds are holding shares in AU:EZZ
---
EZZ Life Science Holdings Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
380.73%
12-Months-Change
Fundamentals
Return on Equity
38.79%
Trailing 12-Months
Asset Growth
44.85%
Trailing 12-Months
Company Description
EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The firm is passionate about investing in the future of consumer health through the development of e-commerce and distribution of high-quality products via omnichannel models across Australia, New Zealand, China and worldwide.
---
Technical Analysis
IDT Australia Limited
―
Medical Developments International Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Memphasys Ltd
―
---